Podcast: Overcoming Regulatory Challenges in a Complex Clinical Trial Landscape

drug approval
• Source: Shutterstock

Don’t miss expert perspectives on the key regulatory and tech elements and challenges faced by biopharma as they navigate the increasingly complicated global regulatory considerations for today’s clinical trials. Explore:

  • Key challenges in developing and managing today’s clinical trials from a regulatory perspective
  • Benefits and limitations of artificial intelligence (AI) in regulatory and compliance
  • The essential element that makes adapting to increasing regulatory complexity easier
  • Strategies for handling future regulatory challenges
  • Outlook for global harmonization of regulatory for clinical trials

Citeline · Podcast: Overcoming regulatory challenges in a complex clinical trial landscape

Open Media

Enjoyed this podcast? Find part one here and part two here

More from Clinical Trials

Bayer Has BI In Its Sights With Priority Review For HER2 Lung Cancer Drug

 
• By 

Sevabertinib gets onto the FDA's approval fast track three months after zongertinib.

InflaRx Stock Sinks As Vilobelimab Fails Phase III Skin Trial

 
• By 

A study of the German biotech's intravenous complement factor C5a antibody for pyoderma gangrenosum was stopped for futility.

Angelini Advances Brain Health Ambitions With GRIN Pact

 
• By 

The Italian drugmaker gets rights to Phase III-ready asset radiprodil.

Sweden’s Hansa Slims Down Ahead of Key Readouts

 
• By 

New CEO Renée Aguiar-Lucander is marking her mark.

More from R&D

In partnership with

Podcast Series: Navigating Regulatory Changes & Market Dynamics: CRO Perspectives on the Future of Clinical Trials

Insights from Novotech on Evolving Trends Impacting Global Clinical Development

Sponsored by:

Making medicines more affordable to the NHS

Delve into the challenges facing the NHS, from rising medicine costs to supply shortages, and how generics and branded generics can provide solutions for a more sustainable healthcare system

Sponsored by:

Japan’s Strengths As A Clinical Study Location And Why Selecting The Right Partner Is Crucial

Learn about the critical role the right CRO plays in successfully navigating the significant drug development opportunities in Japan.

Sponsored by:

Oncology R&D trends at a glance

Access key stats from biotechs on the latest trends impacting oncology R&D, including therapeutic pipelines and clinical trial challenges, AI/ML, and a future outlook on innovation.